What Would Actually Happen if the DEA Rescheduled Cannabis?

In a 25-page memo to Congress last month, the DEA quietly announced it would make a determination on whether to reschedule cannabis from Schedule I — drugs the DEA considers as having high potential for abuse and no medical value — to a lower schedule. Since the announcement, cannabis advocates have been celebrating at the prospect of the federal government finally acknowledging what the medical community and patients have known for years: cannabis has therapeutic value and should not be classified alongside heroin as one of the most dangerous drugs known to mankind. Read more »